Php31 - Impact of European Medicines Agency (Ema) Clinical Trial Transparency Policies on Health Technology Assessment (Hta) Decisions in Germany
Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.927
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV